Amino Acid Analyzer

The object of this procurement is a fully automated amino acid analyzer (also "AAA" or "Device"), all the reagents and equipments required for the analysis and a service agreement. The analyzer is intended for the detection and quantitative analysis of amino acids in physiological fluids: plasma, urine and cerebrospinal fluid. The amino acid profile allows diagnosis and monitoring of inborn errors of metabolism. HUS Logistics, HUSLAB at HUS Diagnostic Center, Helsinki, Finland, aims to purchase an AAA to replace one of the three or replace all three existing analyzers used for the laboratory diagnostics of metabolic diseases in human patient samples. HUSLAB already has three Biochrom Amino Acid Analyzers, one of which is to be replaced. Alternatively, all three with the capacity required are replaced. The reagent and consumable prices provided by the tenderer in this tendering process shall apply during the whole contractual period described in the procurement documentation.

HUSLAB at HUS Diagnostic Center, Helsinki, Finland, purchases an amino acid analyzer (AAA) to replace one of three existing “Biochrom 30+ Amino Acid Analyzer Physiological System” analyzers used for laboratory diagnostics of metabolic diseases in human patient samples. HUSLAB runs approximately 1500 patient samples yearly. HUSLAB will purchase instrumentation and reagents for amino acid analysis based on cation exchange chromatography of precipitated patient samples with post-column derivatization with ninhydrin and dual detection at 570 nm and 440 nm wavelengths. The analyzer must be fully customizable and CE-marked. The procurement will also include CE-marked reagents for 1500 yearly samples and one column per analyzer. Column cleaning and re-packing service are required. Procurement includes training, service agreement with one preventive maintenance service per year, on-site repairs and a telephone hotline. If HUSLAB ends up changing analyzer brand after this tendering process, the whole production capacity of yearly 1500 samples will consequently have to be changed to assure equal measured concentrations and equal processes for all patient samples. The costs for this change are defined in the procurement documentation. The tenderer confirms that it or its representative is not the target of international sanctions. Additional information: https://um.fi/pakotteet (in Finnish) or https://um.fi/internationalsanctions (in English). The procurement authority extends the participation period so that tenders must be submitted on September 21, 2022 at by 12 am.

The procurement authority extends the participation period so that tenders must be submitted on September 21, 2022 at by 12 am.